Stay updated on Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-11-04T01:18:39.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH’s transition notice about using “Super Intelligence” in place of “Artificial Intelligence.” The site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:15:36.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T01:24:21.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Access to the study record now displays a 403 Forbidden page instead of the study content. This blocks core study details and related information from being visible on the page.
    Difference
    18%
    Check dated 2026-09-23T01:14:59.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing the previous v3.6.6. This reflects a backend or template update and does not alter the study content shown to users.
    Difference
    0.1%
    Check dated 2026-09-16T00:31:54.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page's revision version was updated from v3.6.5 to v3.6.6, indicating an editorial update to the page. This change does not alter the study data or how the page presents information.
    Difference
    0.1%
    Check dated 2026-09-01T20:55:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.